features: Trial Updates

Check out our top picks from ESMO 2021!

The U.S. Food and Drug Administration (FDA) has granted accelerated approval of  mobocertinib for patients with metastatic non-small cell lung…

Highlights from ASCO 2021 in lung cancer! Learn more about the major clinical trials reported at this year’s meeting.

VJOncology presents highlights from this year’sEuropean Association of Urology (EAU) Virtual Meeting 2021!

VJOncology brings you highlights in GI cancer from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!

VJOncology presents highlights from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!

VJOncology presents highlights from this year’s virtual European Society for Medical Oncology (ESMO) Breast Cancer Congress!

VJOncology are excited to present some key abstracts and trial updates announced at this year’s virtual St. Gallen Breast Cancer…

VJOncology are pleased to bring you our top picks from the recent virtual WCLC meeting

The de-escalation and treatment personalization of patients with early breast cancer has advanced in recent years, with studies such as…

EPIC-OPC study: misclassification of OPC patients The presence of human papillomavirus p16 alone is not sufficient to classify oropharyngeal cancer…

The first interim results of the Phase III ADAURA study evaluating adjuvant osimertinib in stage IB-IIIA EGFR-mutated non-small cell lung…

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive gastrointestinal malignancy and is often associated with a poor prognosis. Surgery remains…

Seattle Genetics have announced the U.S. Food and Drug Administration (FDA) have granted approval for tucatinib in combination with trastuzumab…